Merkezi Yolla Enjekte Edilen Histamin ve Reseptör Antagonistlerinin, Sıçanların Yem, Su Alımı ve Vücut Ağırlıkları Üzerine Etkileri

Year 2021, Volume: 5 Issue: 2, 210 - 216, 29.08.2021

Burçin Altınbaş Gökçen Güvenç Bayram Murat Yalçın

https://doi.org/10.25048/tudod.968923

Abstract

Amaç: Başta hipotalamus olmak üzere merkezi sinir sisteminde geniş bir dağılım gösteren histamin birçok otonomik işlevin düzenlenmesinde bir nörotransmitter veya nöromodülatör olarak rol almaktadır. Hipotalamusta; yiyecek, su alımı ve vücut ağırlığının düzenlenmesinde görev alan birçok çekirdekte histamin reseptörleri geniş bir dağılıma sahiptir. Çalışmada, merkezi yolla histamin, klorfeniramin, ranitidin ve tiyoperamid tedavilerinin sıçanlarda oluşturduğu yiyecek ve su alımı ile vücut ağırlığı değişimleri araştırılmıştır.
Gereç ve Yöntemler: Çalışma, Sprague-Dawley ırkı sıçanlarda gerçekleştirilmiştir. Histamin (100 nmol), histaminerjik H1 reseptör antagonisti klorfeniramin (100 nmol), histaminerjik H2 reseptör antagonisti ranitidin (100 nmol) veya histaminerjik H3/H4 reseptör antagonisti tiyoperamid (100 nmol) serebral yan ventriküler yolla günde bir kez olacak şekilde 7 gün boyunca enjekte edilmiştir.
Bulgular: Histamin, klorfeniramin ve ranitidinin gıda ve su alımı ile vücut ağırlığında azalmalara neden olmuştur. Fakat tiyoperamid ile yapılan tedavi bahsedilen ilaçların tersine gıda ve su alımı ile vücut ağırlığında artışlara yol açmıştır.
Sonuç: Elde edilen veriler, 7 günlük tedaviler sonrasında merkezi histamin, klorfeniramin ve ranitidin tedavilerinin beslenmenin düzenlenmesinde negatif etkilere yol açtığını göstermektedir. Bunun yanında, merkezi tiyoperamid ile yapılan 7 günlük tedavinin gıda ve su alımı ile kilo alımına neden olduğu ortaya çıkmıştır.

Keywords

Histamin, Histamin antagonistleri, Gıda alımı, Su alımı, Vücut ağırlığı

Effects of Centrally Injected Histamine and Receptor Antagonists on Feed, Water Intake and Body Weight of Rats

Abstract

Aim: The histaminergic system, which has a wide distribution in the central nervous system, especially the hypothalamus, plays a role as a neurotransmitter or neuromodulator in the regulation of many autonomic functions. In the hypothalamus, histamine receptors are widely distributed in many nuclei involved in the regulation of food, water intake, and body weight. In this study, food and water intake and body weight changes caused by histamine, chlorpheniramine, ranitidine, and thioperamide treatments chronically in rats were investigated.
Materials and Methods: The study was carried out in Sprague-Dawley rats. Histamine (100 nmol), histaminergic H1 receptor antagonist chlorpheniramine (100 nmol), histaminergic H2 receptor antagonist ranitidine (100 nmol), or histaminergic H3/H4 receptor antagonist thioperamide (100 nmol) were injected via the cerebral side ventricular route for 7 days. Results: Histamine, chlorpheniramine, and ranitidine caused reductions in food and water intake and body weight. However, treatment with thioperamide led to increases in food and water intake and body weight, unlike the aforementioned drugs.
Conclusion: As a result, the data obtained show that after 7 days of treatments, central histamine, chlorpheniramine, and ranitidine treatments cause negative effects on the regulation of nutrition. In addition, it was revealed that 7 days of treatment with central thioperamide caused weight gain with food and water intake.

Keywords

Histamine, Histamine antagonists, Eating, Drinking, Body weight

References

• 1. Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RL, Lees G, Chazot PL. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol. 2009;157(1):55-63.
• 2. Schwartz JM, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain, Physiol Rev. 1991;71:1–51.
• 3. Wada H, Inagaki N, Yamatodani A, Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity? TINS. 1991;14:415-418.
• 4. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol. 2001;63:637-672.
• 5. Lecklin A, Etu-Seppälä P, Stark H, Tuomisto L. Effects of intracerebroventricularly infused histamine and selective H1, H2 and H3 agonists on food and water intake and urine flow in Wistar rats. Brain Res. 1998;793(1-2):279-288.
• 6. Malmlöf K, Golozoubova V, Peschke B, Wulff BS, Refsgaard HH, Johansen PB, Cremers T, Rimvall K. Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides. Obesity (Silver Spring). 2006;14(12):2154-2162.
• 7. Machidori H, Sakata T, Yoshimatsu H, Ookuma K, Fujimoto K, Kurokawa M, Yamatodani A, Wada H. Zucker obese rats: defect in brain histamine control on feeding, Brain Res. 1992;590:180–186.
• 8. Clineschmidt BV, Lotti VJ. Histamine: intraventricular injection suppresses ingestive behavior of the cat. Arch Int Pharmacodyn Ther. 1973;206:288–298.
• 9. Tuomisto L, Eriksson L. Antidiuresis induced by infusions of histamine into the brain ventricles of conscious goats. Eur J Pharmacol. 1979;54:191–201.
• 10. Lecklin A, Tuomisto L, MacDonald E. Metoprine, an inhibitor of histamine N- methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and food deprived rats. Methods Find Clin Exp Pharmacol. 1995;17:47–52.
• 11. Mercer LP, Kelley DS, Humphries LL, Dunn JD. Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats. J Nutr. 1994;7:1029–1036.
• 12. Haq AU, Bundrant HM, Mercer LP. Food intake is inversely correlated with central nervous system histamine receptor (H1) concentrations in male Sprague-Dawley rats fed normal, low protein, low energy or poor quality protein diets. J Nutr. 1996;126:3083–3089.
• 13. Leibowitz SF. Histamine: a stimulatory effect on drinking behavior in the rat, Brain Res. 1973;63:440–444.
• 14. Clapham J, Kilpatrick GJ. Histamine H3 receptor-mediated modulation of water consumption in the rat, Eur J Pharmacol. 1993;232:99–103.
• 15. Tsuda K, Yoshimatsu H, Niijima A, Chiba S, Okeda T, Sakata T. Hypothalamic histamine neurons activate lipolysis in rat adipose tissue. Exp Biol Med (Maywood ) 2002;227: 208–213.
• 16. Yoshimatsu H, Hidaka S, Niijima A, Sakata T. Histamine neurons down-regulate ob gene expression in rat white adipose tissue. Inflamm Res. 2001;50(suppl 2):72–S73.
• 17. Masaki T, Chiba S, Yasuda T, Noguchi H, Kakuma T, Watanabe T, Sakata T, Yoshimatsu H. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes. 2004;53:2250–2260.
• 18. Fülöp AK, Földes A, Buzás E, Hegyi K, Miklós IH, Romics L, Kleiber M, Nagy A, Falus A, Kovács KJ. Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene. Endocrinology. 2003;144:4306–4314.
• 19. Takahashi K, Suwa H, Ishikawa T, Kotani H. Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest. 2002;110:1791–1799.
• 20. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates (Fourth edition). New York, Academic Press, 2005.
• 21. Taylor KM, Snyder SH. Isotopic microassay ofhistamine, histidine, histidine decarboxylase and histamine methyltransferase in brain tissue. J Neurochem. 1972;19:1343-1358.
• 22. Palacios JM, Wamsley JK, Kuhar MJ. The distribution of histamine H,-receptor in the rat brain: An autoradiographic study. Neuroscience. 1981;6:15-37.
• 23. Yoshimatsu H, Chiba S, Tajima D, Akehi Y, Sakata T. Histidine suppresses food intake through its conversion into neuronal histamine. Exp Biol Med (Maywood). 2002;227(1):63-68.
• 24. Lecklin A, Tuomisto L. The blockade of H1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism. Pharmacol Biochem Behav. 1998;59(3):753-758.
• 25. Ookuma K, Yoshimatsu H, Sakata T, Fujimoto K, Fukagawa K. Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. 1989;490:268–275.
• 26. Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, Wada H. Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res. 1988;441:403–407.
• 27. Arrang JM, Garbarg M, Schwartz JC. Autoinhibition of brain histamine release mediated by a novel class (%) of histamine receptor. Nature. 1983;302:832-837.
• 28. Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC. Highly potent and selective ligands for histamine H3-receptors. Nature. 1987;327:117-123.
• 29. Ookuma K, Sakata T, Fukagawa K, Yoshimatsu H, Kurokawa M, Machidori H, Fujimoto K. Neuronal histamine in the hypothalamus suppresses food intake in rats. BrainRes. 1993;628:235-242.
• 30. Doi T, Sakata T, Yoshimatsu H, Machidori H, Kurokawa, Jayasekara LALW, Niki. Hypothalamic neuronal histamine regulates feeding circadian rhythm in rats. Brain Res. 1994;641:311–318.
• 31. Sakata T, Fukagawa K, Ookuma K, Fujimoto K, Yoshimatsu H, Yamatodani A, Wada H. Hypothalamic neuronal histamine modulates ad libitum feeding by rats. Brain Res. 1990;537:303-306.
• 32. Støa-Birketvedt G. Effect of cimetidine suspension on appetite and weight in overweight subjects. Br Med J. 1993;306:1091-1093.
• 33. Støa-Birketvedt G, Løvhaug N, Vonen B, Florholmen J. H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms. Acta Physiol Scand. 1997;161(4):489-494.
• 34. Haas HL, Sergeeva OA, Selbach O. Histamine in the Nervous System. Physiol Rev. 2008;88:1183-1241.
• 35. Yamamoto K, Rikuya O, Atsushi Y. Effects of a histamine H4 receptor antagonist on cisplatin-induced anorexia in mice. Neurosci Lett. 2018;676:103-107.
• 36. Kalucy RS. Drug-induced weight gain. Drugs. 1980;19:268–278.
• 37. Bugajski J, Janusz Z. Lipolytic responses induced by intracerebroventricular administration of histamine in the rat. Agents Actions. 1981;11:147–150.
• 38. Malmlöf K, Zaragoza F, Golozoubova V, Refsgaard HHF, Cremers T, Raun K, Wulff BS, Johansen PB, Westerink B, Rimvall K. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake, and body weight. Int J Obes (Lond). 2005;29:1402–1412.
• 39. Hancock AA, Bennani YL, Bush EN, Esbenshade TA, Faghih R, Fox GB, Jacobson P, Knourek-Segel V, Krueger KM, Nuss ME, Pan JB, Shapiro R, Witte DG, Yao BB. Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. Eur J Pharmacol. 2004;487:183–197.
• 40. Onodera K, Yamatodani A, Watanabe T, Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol. 1994;42:685–702.
• 41. Kjaer A, Knigge U, Rouleau A, Garbarg M, Warberg J. Dehydration-induced release of vasopressin involves activation of hypothalamic histaminergic neurons. Endocrinology. 1994;135:675-681.
• 42. Kraly FS. Drinking elicited by eating. In: Epstein AN, Morrison A, ed. Progress in Psychobiology and Physiological Psychology. vol. 14. New York, NY: Academic Press;1990:67-133.
• 43. Silva MDC, Ramos AC, Athanazio R, Barbetta M, Fregoneze JB. Central H1 and H2 receptor participation in the control of water and salt intake in rats. Physiol Behav. 2005;84:pp.233-243.